Effect of Oxis on the Efficacy of Mucociliary Clearance in Patients with COPD
- Conditions
- Chronic obstructive pulmonary disease
- Registration Number
- EUCTR2005-000366-39-DE
- Lead Sponsor
- Inamed Research GmbH & Co. KG
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
patients with an established clinical diagnosis of COPD, severity I and IIa according to the GOLD guidelines
FEV1 > 50 % pred
FEV1/FVC < 70%
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Pregnancy and nursing
Present asthma, positive prick test
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: The influence of different medications on mucociliary lung clearance will be investigated;Secondary Objective: not applicable;Primary end point(s): Particle retention after 2 hours
- Secondary Outcome Measures
Name Time Method